Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00047281
Status:
COMPLETED
Last Update Posted:
2017-07-11
First Post:
2002-10-03
Brief Title:
Thalidomide Celecoxib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Brain and Central Nervous System Tumors |